Skip to main content

Mulryne Quoted in BioWorld on Tracking Real World Data During COVID-19

October 21, 2020

Life Sciences & Healthcare Regulatory partner Jacqueline Mulryne was featured as a panelist at the UK BIA Bioscience Forum, discussing the use of real world evidence, and the increased reliance on tracking health data during a global pandemic. The conversation, as summarized in an article from BioWorld, examines the usage of this data by companies and regulators when demonstrating the safety and efficacy of new drugs.

» Read the full article.